He Jiankui

Kevin Davies, executive editor of The CRISPR Journal and author of 'Editing Humanity', discusses the cutting-edge advancements in gene editing, particularly CRISPR's transformative role in treating diseases like sickle cell. He Jiankui's controversial gene editing work raises questions about ethics and oversight in the field. The conversation also emphasizes the balance between innovation and moral responsibility, highlighting accessibility issues and the potential for wealth disparities in accessing gene editing technologies.